Vistagen Therapeutics (VTGN)
Vistagen Therapeutics (VTGN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- VTGN last traded at $0.19 on 2026-11-19, -6.47% for the session.
- Vistagen Therapeutics: market cap $8.62M, revenue $2.38M over the last four quarters, next earnings 2027-02-11.
- Over the past year VTGN returned -95.85%, with a year-to-date return of -71.81%.